Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/07/1981 | US4277465 Enamine derivative |
06/30/1981 | US4276281 Burn treatment |
06/30/1981 | US4276206 Generally applicable method of making immunosuppressive agents |
06/25/1981 | WO1981001709A1 Polypeptides |
06/25/1981 | WO1981001653A1 Sedative drug |
06/25/1981 | WO1981001652A1 Improvements to methods for preparing galenical preparation with delayed action and programmed release and galenical preparations for drugs obtained thereby |
06/24/1981 | EP0030681A1 Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production |
06/23/1981 | US4275000 Peptide macromolecular complexes |
06/23/1981 | US4274830 Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products |
06/17/1981 | EP0030496A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications |
06/17/1981 | EP0030435A1 Dispersible xanthan gum blends |
06/17/1981 | EP0030278A2 A process for the preparation of water insoluble organic dyestuffs |
06/16/1981 | US4273920 Copolymer of lactic and glycolit acids using acid ion exchange resin catalyst |
06/16/1981 | US4273761 Alkali metal salt of polyacrylic acid |
06/16/1981 | US4273714 Tricyclic lactones |
06/16/1981 | CA1103161A1 Oral carrier base, its preparation and dosage units made therefrom |
06/16/1981 | CA1103160A1 Infusion solution for the treatment of hepatic encephalopathy and method of using them |
06/16/1981 | CA1103158A1 Method for preparing biocompatible materials and articles produced thereby |
06/09/1981 | CA1102698A1 Fibrous cellulose product and process |
06/09/1981 | CA1102695A1 Styptic composition |
06/03/1981 | EP0029668A1 Pharmaceutical injectable composition and two-pack container for said composition |
06/03/1981 | EP0029534A2 Solid preparation comprising cobamamide or mecobalamin and process for preparing same |
06/02/1981 | US4271196 Pharmaceutical compositions for parenteral or local administration |
06/02/1981 | US4271150 Urokinase preparation for oral administration |
06/02/1981 | CA1102239A1 No translation available |
05/26/1981 | US4269853 Composition and method for treating skin mast cells and/or delayed cellular hypersensitivity reactions |
05/20/1981 | EP0028917A2 Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances, their use and method of preparing them |
05/20/1981 | EP0028897A1 Preparation of products for human or animal consumption using a sucrose substitute |
05/20/1981 | EP0028813A2 Stable solutions of hydrogenated ergotalcaloids or their salts and heparin or its salts,and process for their preparations |
05/19/1981 | US4268502 Cosmetic tonic formulation |
05/19/1981 | US4268496 Curable organopolysiloxane, cellulose ether coating |
05/19/1981 | CA1101334A1 Topical anti-inflammatory drug therapy |
05/12/1981 | US4267169 Combinations with crotamiton, for use as a fungicide in treating trichophytosis |
05/12/1981 | US4267138 Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients |
05/12/1981 | CA1100875A1 Tetracycline antibiotic compositions |
05/12/1981 | CA1100874A1 Topical pharmaceutical compositions for treating anomalous mobilization and deposition of bone mineral in humans and other animals |
05/05/1981 | US4265888 Acetylsalicylate powder preparation for injection |
04/30/1981 | WO1981001145A1 Hydrolytic enzyme-activatible pro-drugs |
04/29/1981 | EP0027768A1 Acid-type ion exchange resins, their preparation, their use as medicines and compositions containing them |
04/29/1981 | EP0027573A2 Method of stabilizing interferon and composition containing it |
04/29/1981 | EP0027533A1 Photographic materials, process for their production, their use and the use of gelatines |
04/28/1981 | US4264766 Latex carrier reacted with a polyhydroxy compound |
04/28/1981 | CA1100042A1 Absorbable pharmaceutical compositions based on poly(alkylene oxalates) |
04/28/1981 | CA1100041A1 Absorbable pharmaceutical compositions based on isomorphic copolyoxalates |
04/22/1981 | EP0027286A2 Anti-acne composition comprising diisopropyl sebacate |
04/21/1981 | US4263313 Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof |
04/21/1981 | CA1099728A1 Process for the peparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing same |
04/21/1981 | CA1099637A1 Gel composition for topical application |
04/21/1981 | CA1099636A1 Dithranol composition for the treatment of psoriasis |
04/14/1981 | US4262017 Spray drying dispersion of vitamin in solution of lactose and sodium caseinate |
04/14/1981 | US4262007 Method for the treatment of viral skin diseases |
04/14/1981 | US4261973 Suppression of production of reaginic antibodies by injection of conjugate allergen with water-soluble polymer |
04/08/1981 | EP0026599A1 Copolymer from lactic acid and glycolic acid and process for making same |
04/07/1981 | CA1098826A1 Chlorhexidine and/or salt thereof hydrophobic ointments |
03/31/1981 | US4259353 Aqueous solution of l-valine |
03/31/1981 | US4259331 Oxytetracycline compositions |
03/31/1981 | US4259314 Method and composition for the preparation of controlled long-acting pharmaceuticals |
03/31/1981 | CA1098443A1 Absorbable p-dioxanone polymer-drug compositions |
03/25/1981 | EP0025698A2 Controlled release formulations |
03/25/1981 | EP0025697A1 Growth promotant controlled release formulations and method of treatment |
03/25/1981 | EP0025696A2 Controlled release parasiticidal formulations |
03/24/1981 | US4258179 Hydrogel of water-insoluble hydroxypropyl cellulose |
03/24/1981 | US4258055 Pharmaceutical compositions |
03/24/1981 | US4258030 Urokinase preparation for oral administration |
03/24/1981 | CA1098039A1 Intravenous solutions with antimicrobial agent |
03/18/1981 | EP0025302A1 Alpha-mono(methyl-branched alkyl) glyceryl ether and a skin care cosmetic composition containing the same |
03/17/1981 | US4256737 Long acting depot injectable formulations for LH-RH analogues |
03/10/1981 | CA1097448A1 Water-insoluble hydrophilic copolymers |
03/03/1981 | US4254145 Localized vasocilation |
03/03/1981 | US4254104 Process for preparing stable oil-in-water emulsions |
02/24/1981 | US4252796 Aluminum compounds, antiinflammatory agents |
02/24/1981 | US4252794 Gamma-sorbitol polymorph |
02/24/1981 | US4252793 Injectable lecithin preparation |
02/24/1981 | US4252791 Calcium and lanthanide salts, viricides |
02/19/1981 | WO1981000354A1 Method and system for the controlled release of biologically active substances to a body fluid |
02/17/1981 | US4251563 Comprising erythorbyl or ascorbyl laurate or erythorbyl caprate |
02/17/1981 | US4251518 By mixing with polysaccharides derived from soybeans |
02/17/1981 | US4251445 Enzyme conjugates |
02/17/1981 | US4251398 For enhancing other odors, scenting toiletries |
02/17/1981 | CA1095833A1 Controlled release pharmaceutical composition containing mono-sulfuric acid esters of higher fatty alcohols |
02/11/1981 | EP0023779A1 Antitumor protein hybrid and process for the preparation thereof |
02/11/1981 | EP0023772A2 Use of dimethyl isosorbide in liquid formulation of aspirin |
02/10/1981 | US4250267 Curing a mixture of an amine-containing antibiotic and an isocyanate-capped liquid polyetherurethane copolymer |
02/10/1981 | US4250167 Methods for reducing calcium deposits |
02/10/1981 | US4250163 Method and preparation for administration to the mucosa of the oral or nasal cavity |
02/10/1981 | CA1095416A1 Pharmaceutical compositions comprising substituted phenyl-amino-alcohol and process for preparing these compositions |
02/05/1981 | WO1981000207A1 Pharmaceutical preparation |
02/05/1981 | WO1981000206A1 Stable benzoyl peroxide composition |
02/04/1981 | EP0023401A2 Antitumor protein hybrid and process for the preparation thereof |
02/04/1981 | EP0023359A2 Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof |
02/04/1981 | EP0023355A2 Medicinal solutions and process for their preparation |
02/04/1981 | EP0023349A2 Ubidecarenone composition enhancing the absorption |
02/03/1981 | US4248867 Dissolving in saturated middle chain triglyceride pretreated with uv radiation |
02/03/1981 | US4248855 Salt forming nitrogen compound and a polymer containing an acid group for forming a sustained release composition |
01/28/1981 | EP0023178A1 Process for the preparation of concentrated solutions of amygdaline in its natural form |
01/28/1981 | EP0022932A1 Composition with prolonged broncholytic and tokolytic activity, process for preparing it, and broncholytically and tokolytically active agent |
01/27/1981 | US4247702 With a saturated triglyceride |
01/27/1981 | CA1094549A1 Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect |
01/27/1981 | CA1094450A1 Absorbable polymer-drug compounds and method for making same |
01/20/1981 | CA1093971A1 Carcinostatic composition and method of treating a malignant condition |